Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | AZN:LSE since announced | Transaction value |
---|---|---|
Fusion Pharmaceuticals Inc | 14.48% | 2.30bn |
Amolyt Pharma SAS | 12.64% | 1.05bn |
Gracell Biotechnologies Inc | 12.88% | 1.10bn |
Icosavax Inc | 16.68% | 862.87m |
Data delayed at least 20 minutes, as of Sep 20 2024 16:47 BST.
Holder | Shares | % Held |
---|---|---|
Caixa DTVM SAas of 31 May 2024 | 276.07k | 0.00% |
Daycoval Asset Management Administra��o de Recursos Ltda.as of 31 May 2024 | 2.66k | 0.00% |
Data from 31 May 2024 - 31 May 2024Source: FactSet Research Systems Inc.